IMMUNITYBIO INC's ticker is IBRX and the CUSIP is 45256X103. A total of 152 filers reported holding IMMUNITYBIO INC in Q1 2022. The put-call ratio across all filers is 2.71 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $58 | -37.6% | 34,249 | +2.1% | 0.00% | – |
| Q2 2023 | $93 | +52.5% | 33,531 | -0.5% | 0.00% | – |
| Q1 2023 | $61 | -79.5% | 33,705 | -42.6% | 0.00% | – |
| Q4 2022 | $298 | -99.9% | 58,705 | -0.1% | 0.00% | – |
| Q3 2022 | $292,000 | +92.1% | 58,761 | +43.6% | 0.00% | – |
| Q2 2022 | $152,000 | -33.9% | 40,918 | -0.2% | 0.00% | – |
| Q1 2022 | $230,000 | -24.1% | 41,002 | -17.8% | 0.00% | – |
| Q4 2021 | $303,000 | -37.8% | 49,897 | -0.2% | 0.00% | -100.0% |
| Q3 2021 | $487,000 | -40.8% | 50,011 | -13.1% | 0.00% | 0.0% |
| Q2 2021 | $822,000 | +22.9% | 57,556 | +104.1% | 0.00% | 0.0% |
| Q1 2021 | $669,000 | – | 28,200 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ALLEN HOLDING INC /NY | 687,571 | $3,857,000 | 0.50% |
| ORACLE INVESTMENT MANAGEMENT INC | 400,013 | $2,244,000 | 0.44% |
| HARBOURVEST PARTNERS LLC | 335,709 | $1,883,000 | 0.38% |
| Winning Points Advisors, LLC | 60,126 | $339,000 | 0.26% |
| MERIDIAN INVESTMENT COUNSEL INC. | 96,433 | $541,000 | 0.19% |
| SHEETS SMITH WEALTH MANAGEMENT | 203,876 | $1,144,000 | 0.16% |
| Delphia (USA) Inc. | 25,504 | $143,000 | 0.11% |
| Clearwater Capital Advisors, LLC | 147,891 | $830,000 | 0.10% |
| Corton Capital Inc. | 36,843 | $207,000 | 0.09% |
| Virtus ETF Advisers LLC | 27,343 | $153,000 | 0.07% |